¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Infective myositis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • generalized myositis ossificans
    Àü½Å°ñÈ­±Ù(À°)¿°
  • infective
    °¨¿°-
  • infective dose
    °¨¿°¿ë·®, °¨¿°·®
  • infective embolism
    °¨¿°»öÀüÁõ
  • infective endocarditis
    °¨¿°½É³»¸·¿°
  • infective stage
    °¨¿°±â
  • infective thrombosis
    °¨¿°¼ºÇ÷ÀüÁõ
  • multiple myositis
    ´Ù¹ß±Ù(À°)¿°
  • myositis
    ±Ù(À°)¿°
  • myositis ossificans
    °ñÈ­±Ù¿°, »ÀµÇ±â±ÙÀ°¿°
  • myositis ossificans circumspecta
    ±¹ÇѰñÈ­±Ù¿°, ±¹ÇÑ»ÀµÇ±â±ÙÀ°¿°
  • parenchymatous myositis
    ½ÇÁú±Ù(À°)¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • infective
    °¨¿°-
  • myositis
    ±ÙÀ°¿°
  • myositis ossificans
    °ñÈ­±ÙÀ°¿°
  • infective stage
    °¨¿°±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • infective dose
    °¨¿°¿ë·®, °¨¿°·®
  • infective embolism
    °¨¿°»öÀüÁõ
  • infective endocarditis
    °¨¿°½É³»¸·¿°
  • infective
    °¨¿°-
  • infective stage
    °¨¿°±â
  • infective thrombosis
    °¨¿°Ç÷ÀüÁõ
  • generalized myositis ossificans
    Àü½Å°ñÈ­±ÙÀ°¿°
  • myositis
    ±ÙÀ°¿°
  • myositis ossificans
    °ñÈ­±ÙÀ°¿°
  • myositis ossificans circumspecta
    ±¹ÇѰñÈ­±ÙÀ°¿°
  • multiple myositis
    ´Ù¹ß±ÙÀ°¿°
  • parenchymatous myositis
    ½ÇÁú±ÙÀ°¿°
  • purulent myositis
    °í¸§±ÙÀ°¿°, È­³ó±ÙÀ°¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • generalized myositis ossificans
    Àü½Å¼º È­°ñ¼º ±Ù¿°(¡­ûùÍéàõÐÉæú).
  • inclusion body myositis
    ºÀÀÔü ±Ù¿°(¡­ÐÉæú)
  • purulent myositis ³ª m. purulenta
    È­³ó¼º ±Ù¿°(ûùÒÛàõ ÐÉæú)
  • anti-infective
    Ç×°¨¿°¼º, Ç×°¨¿°¾à.
  • anti-infective
    1. Ç×°¨¿°¼º. 2. Ç×°¨¿°¾à.
  • infective
    °¨¿°¼º(Êïæøàõ).
  • infective agent
    °¨¿°ÀÎÀÚ.
  • infective center
    °¨¿°Áß½É.
  • infective dose
    °¨¿° À¯¹ß·®
  • infective eczema
    Àü¿°¼º½ÀÁø
  • infective embolism
    °¨¿°¼º »öÀüÁõ.
  • infective thrombosis
    °¨¿°¼º Ç÷ÀüÁõ.
  • infective zone
    °¨¿°´ë(˧ËçËÀ), Àü¿°´ë (ËøËçËÀ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anti-infective
    Ç×°¨¿°¼º, Ç×°¨¿°¾à.
  • anti-infective
    1. Ç×°¨¿°¼º. 2. Ç×°¨¿°¾à.
  • dose, infective
    °¨¿°·®
  • dose, median tissue culture infective
    50%Á¶Á÷¹è¾ç°¨¿°·®
  • endocarditis infective<³ª>
    °¨¿°¼º.
  • endocarditis,infective
    °¨¿°¼º(Êïæøàõ)
  • infective
    °¨¿°¼º(Êïæøàõ).
  • infective agent
    °¨¿°ÀÎÀÚ.
  • infective center
    °¨¿°Áß½É.
  • infective dose
    °¨¿° À¯¹ß·®
  • infective eczema
    Àü¿°¼º½ÀÁø
  • infective embolism
    °¨¿°¼º »öÀüÁõ.
  • infective thrombosis
    °¨¿°¼º Ç÷ÀüÁõ.
  • infective zone
    °¨¿°´ë(˧ËçËÀ), Àü¿°´ë (ËøËçËÀ).
  • intestine, large,infective enterocolitis
    °¨¿°¼º°£°áÀå¿°(ÊïæøàõÊàÌ¿íóæú)
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • infective form
    °¨¿°Çü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anti-infective vitamin
    Ç×°¨¿°(ù÷Êïæø)ºñŸ¹Î
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myositis
    ±Ù¿°
  • myositis ossificans
    °ñÈ­¼º±Ù¿°
  • myositis ossiflcans circumscripta
    ±¹ÇѼº°ñÈ­¼º±Ù¿°
  • myositis ossiflcans progressiva
    ÁøÇ༺°ñÈ­¼º±Ù¿°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TCID50 median tissue culture infective dose; 50% tissue culture infective dose
DM   1) Diabetes Mellitus
  2) Dermato-Myositis
IBM inclusion body myositis
CoA Coarctation of Aorta
  - Complications
    1. Severe Hypertensi...
IE Infective Endocarditis; °¨¿°¼º ½É³»¸·¿°
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IBM Inclusion body myositis
S-IBM Sporadic inclusion body myositis
IE Infective Endocarditis
IJ infective juvenile
TCID50 tissue culture infective dose
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • M60.0
    Infective myositis
    °¨¿°¼º ±ÙÀ°¿°
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • infective center
    °¨¿° Áß½É
  • infective endarteritis
    °¨¿°¼º µ¿¸Æ³»¸·¿°
  • infective enterocolitis
    °¨¿°¼º °£ °áÀå¿°
  • infective zone
    °¨¿°´ë, Àü¿°´ë
    °¨¿°ÀÇ À§Ç輺ÀÌ ÀÖ´Â ºÎÀ§.
  • ring abscess,in infective endocarditis
    °¨¿°¼º ½É³»¸·¿°ÀÇ
  • infectious myositis
    °¨¿°¼º ±Ù¿°
  • multiple myositis
    ´Ù¹ß ±Ù¿°, ´Ù¹ß¼º ±Ù¿°
  • myositis ossificans
    °ñÈ­¼º ±Ù¿°
    ±ÙÀ° Á¶Á÷ÀÇ °ñÈ­·Î¼­ º¸Åë ¿Ü»ó ÈÄ¿¡ ¹ß»ýÇÑ´Ù.
  • myositis ossificans progressiva
    ÁøÇ༺ °ñÈ­¼º ±Ù¿°
  • myositis purulenta acuta
    ±Þ¼º È­³ó¼º ±Ù¿°
  • noninfectious myositis
    ºñ°¨¿°¼º ±Ù¿°
  • parenchymatous myositis
    ½ÇÁú¼º ±Ù¿°
  • rheumatic myositis
    ·ù¸¶Æ¼½º¼º ±Ù¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
agent, anti-infective Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright.
(12 Dec 1998)
anti-infective <pharmacology> Substances capable of killing infectious agents or of preventing them from spreading and causing infection.
(20 Jun 2000)
anti-infective agents, local Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from disinfectants, which are used on inanimate objects.
(12 Dec 1998)
anti-infective agents, quinolone A group of synthetic antimicrobial agents which usually contain a 4-quinolinone ring structure. A few compounds belonging to this group have related nitrogen heterocyclic ring structures such as naphthyridine or phthalazine groups. All compounds in this group are substituted with an oxo group at the 4-position. The second-generation quinolones are also substituted with a 1-piperazinyl group at the 7-position and a fluorine moiety at the 6-position. The quinolones inhibit the a subunit of DNA gyrase and thus interfere with the ability of the enzyme to repair bacterial DNA breaks during replication. The compounds have a broad spectrum of activity against a variety of aerobic bacteria.
(12 Dec 1998)
anti-infective agents, urinary Substances capable of killing agents causing urinary tract infections or of preventing them from spreading.
(12 Dec 1998)
drug, anti-infective A medication capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright.
(12 Dec 1998)
infective Capable of transmitting an infection.
Synonym: infectious.
(05 Mar 2000)
infective embolism Plugging of an artery by an embolus detached from a suppurating thrombus.
Synonym: infective embolism.
(05 Mar 2000)
infective endocarditis Endocarditis due to infection by microorganisms.
(05 Mar 2000)
infective jaundice Acute onset of malaise, fever, myalgia, nausea, anorexia, abdominal pain, and icterus caused by members of the genus Leptospira.
(05 Mar 2000)
infective thrombus A thrombus formed in septic phlebitis.
(05 Mar 2000)
acute disseminated myositis The occurrence of multiple foci of acute inflammation in the muscular tissue and overlying skin in various parts of the body, accompanied by fever and other signs of systemic infection.
See: dermatomyositis.
Synonym: acute disseminated myositis, pseudotrichinosis, pseudotrichiniasis.
(05 Mar 2000)
cervical myositis See: posttraumatic neck syndrome.
(05 Mar 2000)
multiple myositis The occurrence of multiple foci of acute inflammation in the muscular tissue and overlying skin in various parts of the body, accompanied by fever and other signs of systemic infection.
See: dermatomyositis.
Synonym: acute disseminated myositis, pseudotrichinosis, pseudotrichiniasis.
(05 Mar 2000)
myositis <pathology> Inflammation of a voluntary muscle.
Origin: Gr. Myos = of muscle
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • infective
    INFECTIOUS
  • infective
    ±¼°îÇÏ´Â(À½ÀÌ) ¾ï¾çÀÌ ÀÖ´Â;¾î¹Ì º¯È­¸¦ ÇÏ´Â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á